@Revolution:Global Business News

New Economy, Leadership, Entrepreneurship, Management, Global Business

Archive for the ‘Healthcare’ Category

FDA To Study TV Drug Advertising Methods

Posted by iBlog on August 22, 2007

Federal regulators plan to study whether relaxing, upbeat images featured in TV drug ads distract consumers from warnings about the drugs’ risks.

The announcement, posted Tuesday to the Food and Drug Administration’s Web site, comes a week after a study published in the New England Journal of Medicine suggested the agency’s drug-ad enforcement has steadily declined.

Read the full article in BusinessWeek.com


Posted in Advertising, Current News, Healthcare | Leave a Comment »

Drug Advertising Debate

Posted by iBlog on August 22, 2007

If Representative Henry Waxman (D-Calif.) had his way, the little butterfly used to advertise the insomnia remedy Lunesta might not be allowed to flutter all over our TV screens, as it has incessantly since the drug was approved in late 2004. Waxman believes the U.S. Food & Drug Administration should be able to forbid companies from advertising directly to consumers until new drugs have been on the market for at least three years. He tried to mandate such a restriction by attaching it to a drug-safety bill. But on July 11 he came up short. After a debate centered on drug companies’ right to free speech, the bill passed with virtually all restrictions on drug advertising stripped out (see BusinessWeek.com, 8/6/07, “Dispense with TV Drug Ads”).

Read the full article in BusinessWeek.com

Posted in Advertising, Government, Healthcare, Sales & Marketing | Leave a Comment »

Amgen’s Crisis Play

Posted by iBlog on August 20, 2007

The perils of pushing some drugs too hard and too broadly came home to roost Wednesday as Amgen announced a restructuring that includes laying off as many as 2,600 people and cutting spending by $1.9 billion. Amgen, long regarded as one of the kings of the biotech world, has been under intense scrutiny from the Food and Drug Administration and the Centers for Medicare and Medicaid Services in recent months regarding one of its top-selling drugs, Aranesp, used to treat anemia in patients undergoing chemotherapy.Read the full article in Forbes.com

Posted in Company Reviews, Healthcare | Leave a Comment »

Addressing Global Health

Posted by iBlog on August 9, 2007

The World Health Organization’s (WHO) 3­-by-5 initiative aims to treat 3 million people living with AIDS by the end of 2005. How does the initiative represent a change from past WHO efforts?

The AIDS pandemic is one of the most difficult social, political, economic, and medical problems the world currently faces. AIDS represents the worst disease threat and the most serious social problem humankind has faced for many centuries. The 3-by-5 initiative is part of the global response, which includes prevention, treatment, and care. At the Barcelona AIDS Conference in 2002, the international community set the specific target of delivering treatment to 3 million people by the end of 2005. WHO, the Joint United Nations Programme on HIV/AIDS (UNAIDS), and other partners have put our weight behind this target, which is a key step on the way to universal access to treatment—the goal of our work.

Read the full article in Harvard International Review

Posted in Healthcare, World News | Leave a Comment »

A Perscription for Innovation

Posted by iBlog on August 9, 2007

The Mayo Clinic’s new SPARC lab is driving experimentation at the frontier of health care. How? By getting physicians to think more like designers.

Read the full article in Fastcompany.com

Posted in Creativity & Culture, Healthcare, Innovation | Leave a Comment »

Young Adults Lead In Lacking Healthcare

Posted by iBlog on August 8, 2007

That age group made up 30 percent of the 45 million Americans without health insurance in 2005, according to the nonpartisan Commonwealth Fund.

Young adults, many who are just entering the workforce and can’t afford the high cost of individual insurance, are the big drivers of an increase in uninsured adults, the report said.

Read the full article on Yahoo.com

Posted in Current News, Healthcare | Leave a Comment »

New Drug To Slow Alzheimers

Posted by iBlog on August 7, 2007

NEW YORK (CNNMoney.com) — No drug on the market can block Alzheimer’s, but biotech Myriad Genetics has one in the works that may slow it down.

There are already drugs that treat the symptoms of Alzheimer’s, like Aricept from Pfizer, Exelon from Novartis and Namenda from Forest Labs. These slow the memory deterioration that’s caused by the disease.

Read the full article on cnnmoney.com


Posted in Current News, Healthcare | Leave a Comment »